News
-
-
PRESS RELEASE
VALBIOTIS SA: Valbiotis announces a major new scientific publication on TOTUM-448, an active substance designed to treat metabolic liver disease (MASLD)
Valbiotis announces publication in Scientific Reports on TOTUM-448, active substance for metabolic liver disease, presenting results from human study -
-
-
-
-
-
-
-
PRESS RELEASE
VALBIOTIS SA: Valbiotis recognized by the 2025 Top Santé Award for Valbiotis Plus® Serenity, an innovative solution for emotional balance
Valbiotis receives 2025 Top Santé Award for Valbiotis Plus Serenity, an innovative solution for emotional balance, recognizing scientific excellence and addressing mental well-being